4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Mania: new trials by email Literature Review of Mania trials Research Report on Mania
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BHV-7000 Open-Label Extension Bipolar Mania Study BHV-7000 - Bipolar Disorder | Phase 2 | Terminated | Biohaven Therapeutics Ltd. | 94 | 2024-06-24 | 2025-12-16 |
| Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression Lu AA39959, Placebo, Quetiapine - Bipolar Disorder | Phase 2 | Terminated | H. Lundbeck A/S | 105 | 2008-12-01 | 2014-05-28 |
| Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder Riluzole - Bipolar Disorder, Anxiety Disorders | Phase 2 | Terminated | National Institute of Mental Health (NIMH) | 6 | 2008-11-01 | 2017-09-15 |
| Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression Lu AA34893, Quetiapine fumarate, Placebo - Depression in Patients With Bipolar Disorder | Phase 2 | Terminated | H. Lundbeck A/S | 166 | 2008-01-01 | 2010-09-27 |
Bipolar Disorder (4) · Depression (2) · Anxiety Disorders (1)
Bipolar and Related Disorders (4) · Mental Disorders (4) · Mood Disorders (4) · Nervous System Diseases (4) · Neurobehavioral Manifestations (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Behavior (2) · Behavioral Symptoms (2)
Quetiapine Fumarate (2) · Riluzole (1)
H. Lundbeck A/S (2) · Biohaven Therapeutics Ltd. (1) · National Institute of Mental Health (NIMH) (1)
United States (3) · Australia (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · France (1) · Germany (1) · Lithuania (1) · Malaysia (1) · Philippines (1) · Poland (1) · Romania (1) · Slovakia (1) · South Korea (1)